טוען...
The Role of Incretin Therapy at Different Stages of Diabetes
The pathogenetic mechanisms causing type 2 diabetes are complex, and include a significant reduction of the incretin effect. In patients with type 2 diabetes, GLP-1 secretion may be impaired, while GIP secretion seems unaffected. In contrast, the insulinotropic activity of GIP is severely altered, w...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SBDR - Society for Biomedical Diabetes Research
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3280667/ https://ncbi.nlm.nih.gov/pubmed/22262070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2011.8.323 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|